Growth Stage

Making a Difference, Naturally.

Making a Difference, Naturally.


Raised this Round: Raised: $143,487

Total Commitments ($USD)


Dealmaker Securities

Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common


Series A

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Consumer Products, Goods & Services

Tech Sector



Canoga Park, California

Med-X is raising funds on Dealmaker Securities. The company is revolutionizing the pesticide industry with its clean and green pesticide alternative. Med-X’s Nature-Cide is natural and plant-based and helps in fighting pests without the harmful effects of chemicals. The company has several strategic partnerships and a loyal customer base and has reported a 200% revenue growth to $1.89 million in 2023. Matthew Mills founded Med-X in February 2014. The current crowdfunding campaign has a minimum target of $10,002 and a maximum target of $1.23 million. The campaign proceeds will be used for acquisitions, marketing, working capital, hiring, product registration, and research and development.

Summary Profit and Loss Statement

FY 2023 FY 2022












Net Income



Summary Balance Sheet

FY 2023 FY 2022




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 05/28/2024
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 09/29/2024 Dealmaker Securities $50,894,025 $143,487 Equity - Common Active RegCF
Med-X 11/08/2023 Dalmore Group $102,217,405 $3,936,422 Equity - Common Funded RegA+
Med-X 05/22/2023 PicMii $43,211,544 $0 Equity - Common Not Funded RegCF
Med-X 09/09/2021 truCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/26/2019 StartEngine - $7,000,471 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Med-X on Dealmaker Securities 2024
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $50,894,025
Price per Share: $3.00

Follow company

Follow Med-X on Dealmaker Securities 2024

Buy Med-X's Deal Report

Med-X Deal Report

Get KingsCrowd’s comprehensive report on Med-X including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Med-X is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Med-X deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge